文献速递呼吸道感染呼吸危重症与机械通气

欧洲裔脓毒症相关ARDS的全基因组关联研究

Sepsis-associated acute respiratory distress syndrome in individuals of European ancestry: a genome-wide association study.
PubMed 文献 · Lancet Respir Med · 2020-01-23

BACKGROUND: Acute respiratory distress syndrome (ARDS) is a lung inflammatory process caused mainly by sepsis. Most previous studies that identified genetic risks for ARDS focused on candidates with biological relevance.…

要点

  • FLT1 rs9508032与脓毒症相关ARDS易感性在全基因组水平显著相关。
  • 保护性等位基因进一步降低FLT1启动子活性,提示功能机制。
  • VEGFA与ARDS的关联在文献挖掘中得到验证。

核心结论

  • FLT1基因常见变异与脓毒症相关ARDS易感性相关。
  • 研究支持VEGF信号通路在ARDS发病中起作用,VEGFR-1为潜在治疗靶点。

研究设计与样本

  • 病例对照全基因组关联研究,共1935名欧洲个体,病例为脓毒症相关ARDS,对照为脓毒症无ARDS。
  • 发现阶段纳入2002年1月至2017年1月西班牙ICU网络的672名患者。
  • 对发现与复制阶段结果进行meta分析,并用肺活检RNA测序、计算机分析和荧光素酶报告基因实验评估变异功能。

临床怎么用

  • FLT1变异可能作为脓毒症相关ARDS易感性的遗传标记,但尚未用于临床决策。
  • VEGFR-1为潜在治疗靶点,需进一步转化研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute respiratory distress syndrome (ARDS) is a lung inflammatory process caused mainly by sepsis. Most previous studies that identified genetic risks for ARDS focused on candidates with biological relevance. We aimed to identify novel genetic variants associated with ARDS susceptibility and to provide complementary functional evidence of their effect in gene regulation. METHODS: We did a case-control genome-wide association study (GWAS) of 1935 European individuals, using patients with sepsis-associated ARDS as cases and patients with sepsis without ARDS as controls. The discovery stage included 672 patients admitted into a network of Spanish intensive care units between January, 2002, and January, 2017. The replication stage comprised 1345 individuals from two independent datasets from the MESSI cohort study (Sep 22, 2008-Nov 30, 2017; USA) and the VISEP (April 1, 2003-June 30, 2005) and MAXSEP (Oct 1, 2007-March 31, 2010) trials of the SepNet study (Germany). Results from discovery and replication stages were meta-analysed to identify association signals. We then used RNA sequencing data from lung biopsies, in-silico analyses, and luciferase reporter assays to assess the functionallity of associated variants. FINDINGS: We identified a novel genome-wide significant association with sepsis-associated ARDS susceptibility (rs9508032, odds ratio [OR] 0·61, 95% CI 0·41-0·91, p=5·18 × 10-8) located within the Fms-related tyrosine kinase 1 (FLT1) gene, which encodes vascular endothelial growth factor receptor 1 (VEGFR-1). The region containing the sentinel variant and its best proxies acted as a silencer for the FLT1 promoter, and alleles with protective effects in ARDS further reduced promoter activity (p=0·0047). A literature mining of all previously described ARDS genes validated the association of vascular endothelial growth factor A (VEGFA; OR 0·55, 95% CI 0·41-0·73; p=4·69 × 10-5). INTERPRETATION: A common variant within the FLT1 gene is associated with sepsis-associated ARDS. Our findings support a role for the vascular endothelial growth factor signalling pathway in ARDS pathogenesis and identify VEGFR-1 as a potential therapeutic target. FUNDING: Instituto de Salud Carlos III, European Regional Development Funds, Instituto Tecnológico y de Energías Renovables.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Guillen-Guio B, Lorenzo-Salazar JM, Ma SF, et al. Sepsis-associated acute respiratory distress syndrome in individuals of European ancestry: a genome-wide association study. Lancet Respir Med. 2020. PMID: 31982041. doi:10.1016/S2213-2600(19)30368-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。